Andre Goy is an Oncology physician affiliated with Hackensack University Medical Center. OpenAlex indexes 651 publications with 38,439 citations (h-index 78); ClinicalTrials.gov lists 8 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
92 2nd St
Hackensack, NJ 076012191
Telephone
551-996-3033Provider last certified this registry record 26 Jan 2022.
Clinical trials
- A Study of ABT-199 Plus Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Sponsor: Hackensack Meridian Health
- Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
Sponsor: Hackensack Meridian Health
- Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide
Sponsor: Hackensack Meridian Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Celgene CorporationProgram year20252 payments
- Kite Pharma, Inc.Program year20251 payment
- ABBVIE INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
New England Journal of Medicine
2022 - Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma
British Journal of Haematology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Ghanny, MD
Hackensack University Medical Center
Joseph Parrillo, MD
Hackensack University Medical Center
David Vesole, MD
Hackensack University Medical Center
Caron Rockman, MD
Hackensack University Medical Center
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”